IN MOTION IN MOTION IN MOTION IN MOTION IN MOTION IN MOTION  IN MOTION IN MOTION IN MOTION IN MOTION IN MOTION IN MOTION 

Medicines Management 2025

Australia's Largest Scientific Pharmacy Conference
MCEC, Melbourne, Vic     27.11.25—29.11.25
← Program

Alzheimer's disease: an overview of management

Alzheimer’s care is evolving—are you ready to lead the change? This session delivers key updates on clinical guidelines and explores emerging therapies that are reshaping treatment. Discover how pharmacists can play a pivotal role in improving outcomes and supporting patients and care givers through every stage of care.

This presentation will address the following learning objectives:

  • Summarise current clinical guidelines for the management of Alzheimer’s disease, with a focus on pharmacological and non-pharmacological strategies.
  • Describe emerging therapies and their mechanisms of action in the treatment of Alzheimer’s disease
  • Evaluate the clinical relevance and evidence base of new and evolving treatment options
  • Discuss the pharmacist’s role in supporting patients and caregivers through education, medication management, and care coordination
  • Identify opportunities for pharmacists to contribute to early detection, therapeutic monitoring, and person-centred care in Alzheimer’s disease

Speakers:

Associate Professor Michael Woodward AM Director of Dementia Research and lead clinician, Memory Clinic, Austin Health, Melbourne, Vic

S1
Chair: Paul Firman
Room: 210
Date: Friday 28 November
Time: 1230–1300
Group 2 CPD

More sessions:

S1
Fri 28 Nov, 1200–1230

Kate Tognarini Community Pharmacist; Board Member, Australasian ADHD Professionals Association (AADPA); ADHD Educator and Advocate for Pharmacists, Melbourne, Vic

linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram